1-7 of 7
Susan Blaney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report

Sarah E.S. Leary, Julie R. Park, Joel M. Reid, Andrew T. Ralya, Sylvain Baruchel, Bing Wu, Timothy P.L. Roberts, Xiaowei Liu, Charles G. Minard, Elizabeth Fox, Brenda Weigel, Susan Blaney
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6062–6069.
https://doi.org/10.1158/1078-0432.CCR-16-2882
Published: 12 October 2017
View article titled, Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report
Open the PDF for Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report in another window
Journal Articles

A Phase I and Pharmacokinetic Study of Ecteinascidin-743 (Yondelis) in Children with Refractory Solid Tumors. A Children's Oncology Group Study

Loretta Lau, Jeffery G. Supko, Susan Blaney, Linda Hershon, Nita Seibel, Mark Krailo, Wenchun Qu, David Malkin, Jose Jimeno, Mark Bernstein, Sylvain Baruchel, for the Children's Oncology Group
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 672–677.
https://doi.org/10.1158/1078-0432.672.11.2
Published: 08 February 2005
View article titled, A Phase I and Pharmacokinetic Study of Ecteinascidin-743 (Yondelis) in Children with Refractory Solid Tumors. A Children's Oncology Group Study
Open the PDF for A Phase I and Pharmacokinetic Study of Ecteinascidin-743 (Yondelis) in Children with Refractory Solid Tumors. A Children's Oncology Group Study in another window
Journal Articles

Pharmacokinetics of O6-benzylguanine in Pediatric Patients with Central Nervous System Tumors: A Pediatric Oncology Group Study

Kathleen Neville, Susan Blaney, Mark Bernstein, Patrick Thompson, Denise Adams, Alexander Aleksic, Stacey Berg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5072–5075.
https://doi.org/10.1158/1078-0432.CCR-03-0123
Published: 05 August 2004
View article titled, Pharmacokinetics of O<sup>6</sup>-benzylguanine in Pediatric Patients with Central Nervous System Tumors: <subtitle>A Pediatric Oncology Group Study</subtitle>
Open the PDF for Pharmacokinetics of O<sup>6</sup>-benzylguanine in Pediatric Patients with Central Nervous System Tumors: <subtitle>A Pediatric Oncology Group Study</subtitle> in another window
Journal Articles

Phenylbutyrate and Phenylacetate Induce Differentiation and Inhibit Proliferation of Human Medulloblastoma Cells

Xiao-Nan Li, Suhag Parikh, Qin Shu, Hye-Lim Jung, Chi-Wan Chow, Laszlo Perlaky, Hon-Chiu Eastwood Leung, Jack Su, Susan Blaney, Ching C. Lau
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 1150–1159.
https://doi.org/10.1158/1078-0432.CCR-0747-3
Published: 10 February 2004
View article titled, Phenylbutyrate and Phenylacetate Induce Differentiation and Inhibit Proliferation of Human Medulloblastoma Cells
Open the PDF for Phenylbutyrate and Phenylacetate Induce Differentiation and Inhibit Proliferation of Human Medulloblastoma Cells in another window
Journal Articles

Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary

Peter J. Houghton, Peter C. Adamson, Susan Blaney, Howard A. Fine, Richard Gorlick, Michelle Haber, Lee Helman, Steve Hirschfeld, Melinda G. Hollingshead, Mark A. Israel, Richard B. Lock, John M. Maris, Glenn Merlino, Wendy Patterson, C. Patrick Reynolds, Kevin Shannon, Alice Yu, John Yu, Malcolm A. Smith
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3646–3657.
Published: 01 December 2002
View article titled, Testing of New Agents in Childhood Cancer Preclinical Models: <subtitle>Meeting Summary</subtitle>
Open the PDF for Testing of New Agents in Childhood Cancer Preclinical Models: <subtitle>Meeting Summary</subtitle> in another window
Journal Articles

Dose Escalation and Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Children with Solid Tumors: A Pediatric Oncology Group Study

Neyssa M. Marina, Debon Cochrane, Elaine Harney, Katie Zomorodi, Susan Blaney, Naomi Winick, Mark Bernstein, Michael P. Link
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (2): 413–418.
Published: 01 February 2002
View article titled, Dose Escalation and Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Children with Solid Tumors: <subtitle>A Pediatric Oncology Group Study</subtitle>
Open the PDF for Dose Escalation and Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Children with Solid Tumors: <subtitle>A Pediatric Oncology Group Study</subtitle> in another window
Journal Articles

A Phase I Study of Irinotecan in Pediatric Patients: A Pediatric Oncology Group Study

Susan Blaney, Stacey L. Berg, Charles Pratt, Steve Weitman, Jim Sullivan, Lori Luchtman-Jones, Mark Bernstein
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 32–37.
Published: 01 January 2001
View article titled, A Phase I Study of Irinotecan in Pediatric Patients: A Pediatric Oncology Group Study
Open the PDF for A Phase I Study of Irinotecan in Pediatric Patients: A Pediatric Oncology Group Study in another window